DANOS; Olivier

Patent Applications and Registrations

Patent applications and USPTO patent grants for DANOS; Olivier.The latest application filed is for "methods for the treatment of epilepsy".

Company Profile

2.7.12

DANOS; Olivier - Rockville MD
Danos; Olivier - Princeton NJ
Danos; Olivier - New York NY
Danos; Olivier - Fontainebleau N/A FR
Danos, Olivier - Garches FR
Danos; Olivier - Somerville MA
Danos; Olivier - Paris FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods For The Treatment Of Epilepsy App 20220251567 - CREPEL; Valerie ; et al.	2022-08-11
Recombinant Adeno-associated Viruses And Uses Thereof App 20220186256 - Danos; Olivier ; et al.	2022-06-16
Gene Therapy For Eye Pathologies App 20220143221 - Danos; Olivier ; et al.	2022-05-12
Treatment Of Mucopolysaccharidosis Iva App 20210292789 - Tomatsu; Shunji ; et al.	2021-09-23
Treatment Of Ocular Diseases With Human Post-translationally Modified Vegf-trap App 20210010025 - Danos; Olivier ; et al.	2021-01-14
Fully-human Post-translationally Modified Antibody Therapeutics App 20200093939 - Danos; Olivier ; et al.	2020-03-26
Use of endonucleases for inserting transgenes into safe harbor loci Grant 9,290,748 - Danos , et al. March 22, 2	2016-03-22
Use Of Endonucleases For Inserting Transgenes Into Safe Harbor Loci App 20130227715 - Danos; Olivier ; et al.	2013-08-29
Viral Vectors Encoding A Dna Repair Matrix And Containing A Virion-associated Site Specific Meganuclease For Gene Targeting App 20120272348 - Danos; Olivier ; et al.	2012-10-25
Use of Endonucleases for Inserting Transgenes Into Safe Harbor Loci App 20110239319 - DANOS; Olivier ; et al.	2011-09-29
Adeno-associated viral vector-mediated delivery of DNA to cells of the liver Grant 6,936,243 - Snyder , et al. August 30, 2	2005-08-30
Canine adenovirus vectors for the transfer of genes in targeted cells App 20030100116 - Kremer, Eric ; et al.	2003-05-29
Biocompatible implant for the expression and in vivo secretion of a therapeutic substance App 20020098223 - Moullier, Philippe ; et al.	2002-07-25
Recombinant retroviruses with amphotropic and ecotropic host ranges Grant 5,955,331 - Danos , et al. September 21, 1	1999-09-21
Biocompatible implant for the expression and in vivo secretion of a therapeutic substance Grant 5,906,817 - Moullier , et al. May 25, 1	1999-05-25
Recombinant retroviruses with amphotropic and ecotropic host ranges Grant 5,449,614 - Danos , et al. September 12, 1	1995-09-12
DNA Fragments coding for polypeptides containing at least one antigenic determinant of the papillomavirus, particularly of the HPV 1a type and corresponding polypeptides Grant 4,551,270 - Danos , et al. November 5, 1	1985-11-05

Company Registrations

SEC

0001701180

Danos Olivier

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.